Shares in Hims & Hers Health fell after the U.S. Food and Drug Administration said Eli Lilly's obesity and diabetes drugs are no longer in shortage. Shares were down 7% in premarket trading to $17.64.

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

Eli Lilly’s (NYSE:LLY) blockbuster GLP-1 medication, tirzepatide, is no longer in shortage in the U.S., the U.S. Food and ...

This article like a handy guide can help you choose the right product for you that your physician can integrate into your ...

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

Foods that help digestion, like fruits, dark green vegetables, and whole grains, may aid your digestive health and relieve ...

The best diets are healthy eating patterns that emphasize whole, nutrient-rich plant foods and minimize heavily processed ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

A report from online drug marketplace Universal Drugstore found that pizza was the most popular junk food in America. However ...

These are the most unhealthy fast-food hamburgers in the U.S. ranked, according to a study. Nutritionists explain the ...

Fast food may not traditionally be associated with healthy eating, but everything in moderation—right? Still, not all ...

Powdered drink mix: If you have a lot of water stocked up, you might crave a sugar rush after a while. Sports drinks and ...